Medifast Inc
MED· NYSE
MEDMedifast Inc
Filed Feb 21, 2023 · 10-K · 52 days after period end · 0001628280-23-004341
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $337.25M | $377.83M | $264.91M | $170.63M |
| Net Income | $26.52M | $34.02M | $27.99M | $19.88M |
| EPS Diluted | — | — | $2.36 | $1.66 |
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Feb 21, 2023 · 52 d after period end
